Current status of anti-CD30 monoclonal antibody therapy in anaplastic lymphoma and Hodgkin’s lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 10 [cited 2025 Jul. 4];2(13). Available from: https://journals.pagepress.org/hmr/article/view/483